Business Wire

ADVA

1.12.2022 09:02:15 CET | Business Wire | Press release

Share
ADVA answers on-premises cloud demand with Ensemble Cloudlet

ADVA (FSE: ADV) today expanded its uCPE solution with Ensemble Cloudlet. This new software is a direct response to the growing demand from enterprises for on-premises cloud solutions. With Ensemble Cloudlet, enterprises can harness edge computing to meet low-latency requirements for applications such as private 5G, AR and smart manufacturing. Removing the need for central hosting also boosts security and makes mission-critical applications more resilient. For CSPs, Ensemble Cloudlet creates an entirely new use case for uCPE. It enables them to offer customers an easily scalable edge cloud with localized control. With Ensemble Cloudlet, CSPs can effortlessly deploy and manage tens of thousands of edge clouds to host customer IT workloads, opening up a wealth of new revenue streams.

“Our Ensemble Cloudlet is a key step in the evolution of the cloud. No longer is it something hosted solely in large, centralized data centers. Now it’s easy to harness the benefits of multi-node clouds right on the customer premises. That means enterprises can utilize applications that require access to compute resources with extremely low latency. It also gives organizations with highly sensitive data the ability to keep all information in a specific area for complete data sovereignty,” said Mike Heffner, GM at Edge Cloud, ADVA. “And for CSPs, our Ensemble Cloudlet opens the door to a world of new opportunities. They already have the infrastructure in place to deliver hybrid workload clouds at the customer edge. Now we’re providing the easy scalability and secure remote management capabilities to make it work. CSPs can start with a single node and then scale up to meet customer demand.”

Ensemble Cloudlet extends traditional uCPE deployments by clustering multiple nodes together in a single cloud and delivering managed on-premises edge computing. With zero-touch provisioning, it makes deployment easy for teams without specialized expertise. Far more cost-efficient than data center cloud solutions, Ensemble Cloudlet also boosts resilience through redundant local cloud controllers and by enabling remote management. This is achieved with ADVA’s Ensemble management and orchestration suite, including Ensemble Orchestrator and Ensemble Virtualization Director, which features automation tools that reduce the need for technical resources and expert personnel.

“The launch of our Ensemble Cloudlet is big news for CSPs. The boom in uCPE deployments puts them in the perfect position to create scalable edge clouds with localized control. Now we’re giving them the tools they require to seize this new opportunity,” commented Brian Van Voorhis, director of PLM at Edge Cloud, ADVA. “For a growing number of applications, the model of a centralized data center cloud just doesn’t fit. Now CSPs can give customers access to the local cloud computing they need for use cases including VR and industrial IoT. From providing standalone resilience when network links fail to reducing backhaul for applications such as video surveillance, our Ensemble Cloudlet will be a game changer.”

Further details on Ensemble Cloudlet are available in this solution brief: https://adva.li/ensemble-cloudlet-solution-brief.

Supporting slides are also available: https://adva.li/ensemble-cloudlet-slides.

About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005854/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release

Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release

Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

Speech Processing Solutions Launches Philips SpeechLive Legal AI Assistant for Faster, More Accurate Legal Document Creation5.8.2026 15:37:00 CEST | Press release

The new SpeechLive Legal AI Assistant reduces the administrative burden on legal professionals through customizable document drafting powered by speech recognition tuned for legal terminology Speech Processing Solutions, the global leader in AI-assisted professional dictation and documentation solutions sold under the Philips brand, today announced the Philips SpeechLive Legal AI Assistant. The new solution transforms voice recordings, dictation and uploaded sources into structured, ready-to-review legal documents, helping legal professionals work faster while retaining control of the final draft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805997413/en/ The new Philips SpeechLive Legal AI Assistant is designed for turning conversations into ready-to-review legal document drafts. SpeechLive Legal significantly reduces the time needed to transform voice input into structured legal documentation, delivering consistent an

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye